Literature DB >> 22786591

Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk.

David Nolan1, Alison Castley, Monika Tschochner, Ian James, Wei Qiu, David Sayer, Frank T Christiansen, Campbell Witt, Frank Mastaglia, William Carroll, Allan Kermode.   

Abstract

OBJECTIVE: The identification of a vitamin D-responsive (VDRE) motif within the HLA-DRB1*15:01 promoter region provides an attractive explanation for the combined effects of HLA-DR inheritance and vitamin D exposure on multiple sclerosis (MS) risk. We therefore sought to incorporate HLA-DRB1 promoter variation, including the VDRE motif, in an assessment of HLA-DRB1-associated MS risk.
METHODS: We utilized 32 homozygous HLA cell lines (covering 17 DRB1 alleles) and 53 heterozygote MS samples (20 DRB1 alleles) for HLA-DRB1 promoter sequencing. The influence of HLA-DRB1 variation on MS risk was then assessed among 466 MS cases and 498 controls.
RESULTS: The majority of HLA*DRB1 alleles (including HLA-DRB1*15:01) express the functional VDRE motif, apart from HLA-DRB1*04, *07, and *09 alleles that comprise the HLA-DR53 serologic group. Allele-specific variation within functional X-box and Y-box motifs was also associated with serologically defined HLA-DR haplotypes. Incorporating these results in an analysis of MS risk, we identified a strong protective effect of HLA-DRB1*04, *07, and *09 (DR53) alleles (p = 10(-12)) and elevated risk associated with DRB1*15 and *16 (DR51) and *08 (DR8) alleles (p < 10(-18)).
CONCLUSIONS: HLA-DRB1 groups corresponding to serologic HLA-DR profiles as well as promoter polymorphism haplotypes effectively stratified MS risk over an 11-fold range, suggesting functional relationships between risk-modifying HLA-DRB1 alleles. An independent contribution of VDRE motif variation to increase MS risk was not discernible, although vitamin D-dependent regulation of HLA-DR expression may still play an important role given that HLA-DRB1*04/*07/*09 (DR53) alleles that express the "nonresponsive" VDRE motif were associated with significantly reduced risk of MS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22786591     DOI: 10.1212/WNL.0b013e318263c407

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

2.  Genetic predictors of relapse rate in pediatric MS.

Authors:  Jennifer S Graves; Lisa F Barcellos; Xiaorong Shao; Janelle Noble; Ellen M Mowry; Hong Quach; Anita Belman; T Charles Casper; Lauren B Krupp; Emmanuelle Waubant
Journal:  Mult Scler       Date:  2016-01-14       Impact factor: 6.312

3.  The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States.

Authors:  A H Beecham; L Amezcua; A Chinea; C P Manrique; C Rubi; N Isobe; B T Lund; A Santaniello; G W Beecham; E G Burchard; M Comabella; N Patsopoulos; K Fitzgerald; P A Calabresi; P De Jager; D V Conti; S R Delgado; J R Oksenberg; J L McCauley
Journal:  Mult Scler       Date:  2019-08-01       Impact factor: 5.855

4.  What is the Real Fate of Vitamin D in Multiple Sclerosis?

Authors:  Vahid Shaygannejad; Zahra Tolou-Ghamari
Journal:  Int J Prev Med       Date:  2013-05

5.  Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.

Authors:  Monika Tschochner; Shay Leary; Don Cooper; Kaija Strautins; Abha Chopra; Hayley Clark; Linda Choo; David Dunn; Ian James; William M Carroll; Allan G Kermode; David Nolan
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

6.  HLA alleles modulate EBV viral load in multiple sclerosis.

Authors:  Simone Agostini; Roberta Mancuso; Franca R Guerini; Sandra D'Alfonso; Cristina Agliardi; Ambra Hernis; Milena Zanzottera; Nadia Barizzone; Maurizio A Leone; Domenico Caputo; Marco Rovaris; Mario Clerici
Journal:  J Transl Med       Date:  2018-03-27       Impact factor: 5.531

7.  Is multiple sclerosis progression associated with the HLA-DR15 haplotype?

Authors:  Klarissa Hanja Stürner; Inessa Siembab; Gerhard Schön; Jan-Patrick Stellmann; Nika Heidari; Boris Fehse; Christoph Heesen; Thomas H Eiermann; Roland Martin; Thomas Mc Binder
Journal:  Mult Scler J Exp Transl Clin       Date:  2019-12-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.